Skip to main content
S 1348 115th Congress Senate Health Civil actions and liability Corporate finance and management Government information and archives Inflation and prices Marketing and advertising Prescription drugs Research and development

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

Introduced: June 13, 2017 Introduced by: Wyden, Ron Democratic · Oregon See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2017
Read twice and referred to the Committee on Finance.
Jun 13, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of  drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.

A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.

What's happening now June 13, 2017

Read twice and referred to the Committee on Finance.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 3
D
Duckworth, Tammy
Illinois · Aug 2, 2017
 D
Coons, Christopher A.
Delaware · Jun 13, 2017
 D
Gillibrand, Kirsten E.
New York · Jun 13, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-1348/
MLA
"S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1348/.
Bluebook (legal)
S. 1348, 115th Cong. (2026), https://openamerica.io/bill/115-S-1348/.
Markdown link
[S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017](https://openamerica.io/bill/115-S-1348/)
Report a problem